Stifel Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
189,406
-498
| -0.3% | -$4.03K | ﹤0.01% | 2035 |
|
|
2025
Q1 | $1.59M | Buy |
189,904
+1,465
| +0.8% | +$12.3K | ﹤0.01% | 1921 |
|
|
2024
Q4 | $1.49M | Buy |
188,439
+337
| +0.2% | +$2.67K | ﹤0.01% | 1983 |
|
|
2024
Q3 | $1.57M | Sell |
188,102
-378
| -0.2% | -$3.15K | ﹤0.01% | 1935 |
|
|
2024
Q2 | $1.2M | Buy |
188,480
+379
| +0.2% | +$2.41K | ﹤0.01% | 2050 |
|
|
2024
Q1 | $1.14M | Buy |
188,101
+3,336
| +2% | +$20.2K | ﹤0.01% | 2104 |
|
|
2023
Q4 | $1.12M | Sell |
184,765
-915
| -0.5% | -$5.55K | ﹤0.01% | 2077 |
|
|
2023
Q3 | $784K | Buy |
185,680
+39,204
| +27% | +$165K | ﹤0.01% | 2212 |
|
|
2023
Q2 | $454K | Buy |
146,476
+462
| +0.3% | +$1.43K | ﹤0.01% | 2577 |
|
|
2023
Q1 | $203K | Buy |
146,014
+5,800
| +4% | +$8.06K | ﹤0.01% | 3044 |
|
|
2022
Q4 | $279K | Buy |
140,214
+246
| +0.2% | +$490 | ﹤0.01% | 2803 |
|
|
2022
Q3 | $283K | Buy |
139,968
+11,254
| +9% | +$22.8K | ﹤0.01% | 2752 |
|
|
2022
Q2 | $409K | Buy |
128,714
+3,391
| +3% | +$10.8K | ﹤0.01% | 2580 |
|
|
2022
Q1 | $523K | Buy |
125,323
+37,543
| +43% | +$157K | ﹤0.01% | 2550 |
|
|
2021
Q4 | $420K | Buy |
87,780
+67,917
| +342% | +$325K | ﹤0.01% | 2696 |
|
|
2021
Q3 | $106K | Buy |
+19,863
| New | +$106K | ﹤0.01% | 3237 |
|
|
2019
Q2 | – | Sell |
-587,615
| Closed | -$8.3M | – | 2960 |
|
|
2019
Q1 | $8.3M | Buy |
587,615
+8,648
| +1% | +$122K | 0.02% | 606 |
|
|
2018
Q4 | $7.81M | Buy |
578,967
+134,910
| +30% | +$1.82M | 0.03% | 568 |
|
|
2018
Q3 | $9.91M | Sell |
444,057
-173,438
| -28% | -$3.87M | 0.03% | 549 |
|
|
2018
Q2 | $10.1M | Buy |
+617,495
| New | +$10.1M | 0.03% | 534 |
|